Antigen epitope and mutant of lyase in gamma bacteriophage of anthrax bacillus, and application
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- INST OF BIOENG ACAD OF MILITARY MEDICAL SCI OF THE CHINESE
- Publication Date
- 2007-07-25
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to an antigenic epitope of Bacillus anthracis γ phage lyase and its mutant and its application, in particular to an antigenic epitope of Bacillus anthracis T phage lyase and its mutant in the diagnosis, prevention and / or preparation of anthrax application in therapeutic drugs. Background technique
[0002] Anthrax is a zoonotic acute infectious disease caused by Bacillus anthracis. The main susceptible animals are sheep, cattle, horses and other herbivorous livestock. The blood of dead animals that die of anthrax does not coagulate, and often discharges a large amount of blood with natural channels. Germs. Due to the different routes of infection, anthrax is clinically divided into skin type, gastrointestinal type and inhalation infection type. Cutaneous anthrax is more common, mainly manifested as skin anthrax pain in exposed parts; gastrointestinal anthrax is relatively rare, in addition to fever and gastrointestinal s...